Federico Rojas-Quijano

Title: Federico Rojas-Quijano: Innovator in Cancer Treatment

Introduction

Federico Rojas-Quijano is a notable inventor based in Bedford, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of targeted therapies. His work focuses on utilizing advanced techniques to improve the efficacy of cancer treatments.

Latest Patents

Rojas-Quijano holds a patent for a groundbreaking invention titled "Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives." This patent describes a cancer-targeting composition, kit, and method for treating cancer cells that overexpress somatostatin receptors. The composition includes a radioisotope, a chelator, and a targeting moiety. The chelator features a nitrogen ring structure that includes a tetraazacyclododecane, a triazacyclononane, and/or a tetraazabicyclo [6.6.2] hexadecane derivative. The targeting moiety consists of a somatostatin receptor targeting peptide, which includes an octreotide derivative. This innovative approach allows for the targeted elimination of cancer cells.

Career Highlights

Throughout his career, Rojas-Quijano has worked with several prominent companies in the medical field. Notably, he has been associated with Radiomedix Inc. and Orano Med. His experience in these organizations has contributed to his expertise in developing advanced cancer treatment methodologies.

Collaborations

Rojas-Quijano has collaborated with talented professionals in his field, including Izabela Tworowska and Nilesh Wagh. These collaborations have further enhanced his research and development efforts in cancer treatment.

Conclusion

Federico Rojas-Quijano is a pioneering inventor whose work in cancer treatment showcases the potential of targeted therapies. His innovative patent and collaborations highlight his commitment to advancing medical science and improving patient outcomes.